{
    "code": "02018224",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02018224",
    "time": "2016-11-18 19:27:30",
    "許可證字號": "衛署藥輸字第018224號",
    "註銷狀態": "已註銷",
    "註銷日期": "94\/06\/03",
    "註銷理由": "未展延而逾期者",
    "有效日期": "89\/08\/24",
    "發證日期": "79\/08\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201822409",
    "中文品名": "克老蒙錠",
    "英文品名": "CLERMON TABLET",
    "適應症": "血液循環不全起因之障害",
    "劑型": "110錠劑",
    "包裝": "盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "KALLIDINOGENASE(KALLIKREIN)"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1416201100  鼎明貿易股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260321000  TAIYO PHARMACEUTICAL INDUSTRY CO. LTD.",
        "製造廠廠址": "1040-22 MATSUNOKI-CHO, TAKAYAMA CITY, GIFU PREFECTUREJAPAN.3-24-2 AOI, HIGASHI-KU, NAGOYA CITY JAPAN",
        "製造廠公司地址": "3-24-2 AOI, HIGASHI-KU, NAGOYA CITY JAPAN",
        "": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "4400001200",
            "成分名稱": "KALLIDINOGENASE (KALLIKREIN)",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "IU (I"
        }
    ]
}